Skip Ribbon Commands
Skip to main content
Sign In

22935 Troponin I

Troponin I
Test Code: TNI
Synonyms/Keywords

High sensitivity troponin, TNIOH, TNI2H​

Useful For
Exclusion diagnosis of acute myocardial infarction.
Specimen Requirements

Specimen Type Preferred Container/Tube Acceptable Container/Tube Specimen Volume ​Specimen Minimum Volume
(allows for 1 repeat)

Plasma or Serum* 

Lithium-heparin Plasma Separator Tube (PST)
*Serum Separator Tube (SST), Red Top Tube (RTT)​ 1.0 mL​ 0.3 mL​

*Serum samples only acceptable at Marshfield, Minocqua, and Park Falls

Collection Processing Instructions
Specimen must be free of particulate matter including fibrin which can interfere with the assay.
Specimen Stability Information
Specimen Type Temperature Time
Plasma/Serum ​ ​ ​ ​ Ambient​ 4 hours capped
Refrigeratee
< 48 hours
​Frozen at -20 deg Celsius ​1 month
​Frozen at -70 deg Celsius > 1 month
Rejection Criteria

Specimens exposed to repeated freeze/thaw cycles.

Plasma from Sodium Heparin tubes.

Interference

High doses of exogenous biotin (also termed Vitamin B7, Vitamin H or Coenzyme R) may interfere with this assay.

Heterophile Antibodies and Rheumatoid factor can react with reagent immunoglobulins.  Human anti-mouse antibodies may cause falsely low or high results.  Troponin autoantibodies may interfere. 

Performing Laboratory Information
Performing Location Day(s) Test Performed Analytical Time Methodology/Instrumentation
​MMC-Beaver Dam​Monday through Sunday​Less than 2 hours​Chemiluminescent Immunoassay/Siemens Dimension
MMC-​Eau Claire ​Monday through Sunday​ ​​Less than 2 hour​s two-site immunoenzymatic assay/Beckman access2/DXI
MMC-Park Falls
​Monday through Sunday​ ​​Less than 2 hour​s ​Chemiluminescent Immunoassay/Siemens Dimension
​Ladysmith
​Monday through Sunday
​Less than 2 hours
two-site immunoenzymatic assay/Beckman access2/DXI
MMC-Marshfield​
Monday through Sunday​ Less than 1 hour​ Chemiluminescent Immunoassay/Siemens Centaur
MMC-​Minocqua ​Monday through Sunday​ ​​Less than 2 hour​s two-site immunoenzymatic assay/Beckman access2/DXI
MMC-​Neillsville​​Monday through Sunday​​Less than 2 hour​sChemiluminescent Immunoassay/Siemens Dimension
​MMC-Park Falls​Monday through Sunday​Less than 2 hourstwo-site immunoenzymatic assay/Beckman access2/DXI
MMC-​Rice Lake​Monday through Sunday ​Less than 2 hourstwo-site immunoenzymatic assay/Beckman access2/DXI
MMC-​Stevens Point​Monday through Sunday​​Less than 2 hour​stwo-site immunoenzymatic assay/Beckman access2/DXI
​MMC-Weston​Monday through Sunday​Less than 2 hours​Chemiluminescent Immunoassay/Atellica
​Wisconsin Rapids ​Monday through Sunday ​Less than 2 hours ​Chemiluminescent Immunoassay/Siemens Dimension
Reference Range Information
Performing LocationReference Range
​Minocqua/Park Falls (Beckman Coulter DXI)
​Female:  <=15 ng/L
    Male:  <=20 ng/L
Marshfield - Siemens Centaur

Female: <= 37 ng/L
    Male: <= 57 ng/L
​All other Regional Sites (Siemens Dimension)
​Female:  <= 51 ng/L
    Male:  <= 76 ng/L
The 99th percentile Upper Reference Limit (URL) for troponin I in a normal reference population is used. All assays show less than 10% imprecision (<10% CV) at 99th percentile upper reference limit value. Reference values were adopted and validated from the manufacturer's normal population studies.
Interpretation

Serial measurements may be necessary to confirm or exclude the diagnosis of acute coronary syndrome. Repeat testing in 2 hours if clinically indicated.

-If zero hour TNI is <8 ng/L  AND  delta at two hours is < 7 ng/L, then rule out Acute MI.

-If zero hour TNI is >=120 ng/L  OR  delta at two hours is >=20 ng/L, then rule in Acute MI.

-If results do not fall into above, then observe. Getting additional draws (e.g. at 4 hours) may be helpful.

Cardiac Troponin I (cTnI) is very specific to myocardium and not expressed during any developmental stage in skeletal muscle. Increased levels of cTnI are detected with myocardial injury. Detection of rise and/or fall of cTnI are essential to establish the diagnosis of acute myocardial infarction (MI). An increased cTnI concentration is defined as a value exceeding the upper reference limit of the 99th percentile of a normal reference population and is designated as the decision limit for the diagnosis of acute MI (Third Universal definition of Myocardial infarction, ESC/ACCF/AHA/WHF Expert consensus document. Circulation 2012; 126: 2020). Demonstration of rising and/or falling pattern is required to distinguish acute from elevations of cTnI levels that are associated with chronic heart diseases.

A positive cTnI result therefore, is not always indicative of ischemia. Other conditions resulting in myocardial cell damage can contribute to elevated cTnI include, but are not limited to:

Elevated Tnl Values in Patients Without AMI

Cardiac conditions

•  Angina/Unstable Angina

•  Atrial fibrillation

•   Cardiac surgery

•  Cardiomyopathy

•  Congestive heart failure

•  Coronary artery disease

•   Heart failure

•   Hypertensive urgency

•   Myocarditis

•   Pericarditis

•  Pulmonary emoblism

•   Recent cardiac intervention

•   Severe valvular heart disease

•   Tachycardia

 

Non-cardiac conditions

•   Chronic lung disease

•   Cardiac contusion related to a traumatic injury

•   Renal failure

•   Pneumonia

•   Pulmonary embolism

For assessing acute MI, blood samples should be drawn at the time of admission and repeated at 3 to 6 hours intervals. On certain occasions additional samples between 12 and 24 hours may be required if earlier measurements are not elevated and clinical suspicion is high for MI.

Nationally, there is no consensus on whether elevated troponin ought to be called to the ordering clinician as a critical value. It is widely acknowledged that laboratory results requiring critical value callback take longer to appear in the medical record. As Marshfield Clinic was an early adopter of electronic medical records, it is not surprising that reporting efficiency has taken precedence over person-to-person contact for elevated troponin levels. In other words, when myocardial injury or infarction is suspected, the ordering provider is awaiting the troponin value, and patients are generally not released before a result is reported. This is in contrast to critical values such as low platelet count or potassium level (placement of a CBC or electrolyte order does not mean that a clinician is expecting a medically emergent result, so the critical value policy ensures information is received in a timely manner). The laboratory has optimized assay workflow for rapid reporting of troponins and therefore will not call abnormal TNI results.

At the request of an inquiring clinician, the policy was reviewed July 2022 with laboratory professionals and practicing physicians, including clinicians in leadership roles Clinic-wide (Institution for Quality, Innovation and Safety and Board of Directors). The consensus opinion is that in standard of care medical practice, providers ordering a troponin in the outpatient setting, based on concern for myocardial injury, and should monitor patients in the clinic until a result is available. As such, the laboratory's role in optimizing patient care is to strive for highest accuracy and turn-around time, and to be available to answer clinician questions about the troponin assay and results, rather than interfering with the efficiency of the current reporting process.

Dr. Richard Vander Heide, Marshfield Labs Service Line Medical Director             

Outreach CPTs
CPT Modifier
(if needed)
Quantity Description Comments
84484 ​
Synonyms/Keywords

High sensitivity troponin, TNIOH, TNI2H​

Ordering Applications

Ordering Application Description
​Cerner ​HS Troponin I (Single)

If the ordering application you are looking for is not listed, contact your local laboratory for assistance.
Specimen Requirements

Specimen Type Preferred Container/Tube Acceptable Container/Tube Specimen Volume ​Specimen Minimum Volume
(allows for 1 repeat)

Plasma or Serum* 

Lithium-heparin Plasma Separator Tube (PST)
*Serum Separator Tube (SST), Red Top Tube (RTT)​ 1.0 mL​ 0.3 mL​

*Serum samples only acceptable at Marshfield, Minocqua, and Park Falls

Collection Processing
Specimen must be free of particulate matter including fibrin which can interfere with the assay.
Specimen Stability Information
Specimen Type Temperature Time
Plasma/Serum ​ ​ ​ ​ Ambient​ 4 hours capped
Refrigeratee
< 48 hours
​Frozen at -20 deg Celsius ​1 month
​Frozen at -70 deg Celsius > 1 month
Rejection Criteria

Specimens exposed to repeated freeze/thaw cycles.

Plasma from Sodium Heparin tubes.

Interference

High doses of exogenous biotin (also termed Vitamin B7, Vitamin H or Coenzyme R) may interfere with this assay.

Heterophile Antibodies and Rheumatoid factor can react with reagent immunoglobulins.  Human anti-mouse antibodies may cause falsely low or high results.  Troponin autoantibodies may interfere. 

Useful For
Exclusion diagnosis of acute myocardial infarction.
Reference Range Information
Performing LocationReference Range
​Minocqua/Park Falls (Beckman Coulter DXI)
​Female:  <=15 ng/L
    Male:  <=20 ng/L
Marshfield - Siemens Centaur

Female: <= 37 ng/L
    Male: <= 57 ng/L
​All other Regional Sites (Siemens Dimension)
​Female:  <= 51 ng/L
    Male:  <= 76 ng/L
The 99th percentile Upper Reference Limit (URL) for troponin I in a normal reference population is used. All assays show less than 10% imprecision (<10% CV) at 99th percentile upper reference limit value. Reference values were adopted and validated from the manufacturer's normal population studies.
Interpretation

Serial measurements may be necessary to confirm or exclude the diagnosis of acute coronary syndrome. Repeat testing in 2 hours if clinically indicated.

-If zero hour TNI is <8 ng/L  AND  delta at two hours is < 7 ng/L, then rule out Acute MI.

-If zero hour TNI is >=120 ng/L  OR  delta at two hours is >=20 ng/L, then rule in Acute MI.

-If results do not fall into above, then observe. Getting additional draws (e.g. at 4 hours) may be helpful.

Cardiac Troponin I (cTnI) is very specific to myocardium and not expressed during any developmental stage in skeletal muscle. Increased levels of cTnI are detected with myocardial injury. Detection of rise and/or fall of cTnI are essential to establish the diagnosis of acute myocardial infarction (MI). An increased cTnI concentration is defined as a value exceeding the upper reference limit of the 99th percentile of a normal reference population and is designated as the decision limit for the diagnosis of acute MI (Third Universal definition of Myocardial infarction, ESC/ACCF/AHA/WHF Expert consensus document. Circulation 2012; 126: 2020). Demonstration of rising and/or falling pattern is required to distinguish acute from elevations of cTnI levels that are associated with chronic heart diseases.

A positive cTnI result therefore, is not always indicative of ischemia. Other conditions resulting in myocardial cell damage can contribute to elevated cTnI include, but are not limited to:

Elevated Tnl Values in Patients Without AMI

Cardiac conditions

•  Angina/Unstable Angina

•  Atrial fibrillation

•   Cardiac surgery

•  Cardiomyopathy

•  Congestive heart failure

•  Coronary artery disease

•   Heart failure

•   Hypertensive urgency

•   Myocarditis

•   Pericarditis

•  Pulmonary emoblism

•   Recent cardiac intervention

•   Severe valvular heart disease

•   Tachycardia

 

Non-cardiac conditions

•   Chronic lung disease

•   Cardiac contusion related to a traumatic injury

•   Renal failure

•   Pneumonia

•   Pulmonary embolism

For assessing acute MI, blood samples should be drawn at the time of admission and repeated at 3 to 6 hours intervals. On certain occasions additional samples between 12 and 24 hours may be required if earlier measurements are not elevated and clinical suspicion is high for MI.

Nationally, there is no consensus on whether elevated troponin ought to be called to the ordering clinician as a critical value. It is widely acknowledged that laboratory results requiring critical value callback take longer to appear in the medical record. As Marshfield Clinic was an early adopter of electronic medical records, it is not surprising that reporting efficiency has taken precedence over person-to-person contact for elevated troponin levels. In other words, when myocardial injury or infarction is suspected, the ordering provider is awaiting the troponin value, and patients are generally not released before a result is reported. This is in contrast to critical values such as low platelet count or potassium level (placement of a CBC or electrolyte order does not mean that a clinician is expecting a medically emergent result, so the critical value policy ensures information is received in a timely manner). The laboratory has optimized assay workflow for rapid reporting of troponins and therefore will not call abnormal TNI results.

At the request of an inquiring clinician, the policy was reviewed July 2022 with laboratory professionals and practicing physicians, including clinicians in leadership roles Clinic-wide (Institution for Quality, Innovation and Safety and Board of Directors). The consensus opinion is that in standard of care medical practice, providers ordering a troponin in the outpatient setting, based on concern for myocardial injury, and should monitor patients in the clinic until a result is available. As such, the laboratory's role in optimizing patient care is to strive for highest accuracy and turn-around time, and to be available to answer clinician questions about the troponin assay and results, rather than interfering with the efficiency of the current reporting process.

Dr. Richard Vander Heide, Marshfield Labs Service Line Medical Director             

For more information visit:
Performing Laboratory Information
Performing Location Day(s) Test Performed Analytical Time Methodology/Instrumentation
​MMC-Beaver Dam​Monday through Sunday​Less than 2 hours​Chemiluminescent Immunoassay/Siemens Dimension
MMC-​Eau Claire ​Monday through Sunday​ ​​Less than 2 hour​s two-site immunoenzymatic assay/Beckman access2/DXI
MMC-Park Falls
​Monday through Sunday​ ​​Less than 2 hour​s ​Chemiluminescent Immunoassay/Siemens Dimension
​Ladysmith
​Monday through Sunday
​Less than 2 hours
two-site immunoenzymatic assay/Beckman access2/DXI
MMC-Marshfield​
Monday through Sunday​ Less than 1 hour​ Chemiluminescent Immunoassay/Siemens Centaur
MMC-​Minocqua ​Monday through Sunday​ ​​Less than 2 hour​s two-site immunoenzymatic assay/Beckman access2/DXI
MMC-​Neillsville​​Monday through Sunday​​Less than 2 hour​sChemiluminescent Immunoassay/Siemens Dimension
​MMC-Park Falls​Monday through Sunday​Less than 2 hourstwo-site immunoenzymatic assay/Beckman access2/DXI
MMC-​Rice Lake​Monday through Sunday ​Less than 2 hourstwo-site immunoenzymatic assay/Beckman access2/DXI
MMC-​Stevens Point​Monday through Sunday​​Less than 2 hour​stwo-site immunoenzymatic assay/Beckman access2/DXI
​MMC-Weston​Monday through Sunday​Less than 2 hours​Chemiluminescent Immunoassay/Atellica
​Wisconsin Rapids ​Monday through Sunday ​Less than 2 hours ​Chemiluminescent Immunoassay/Siemens Dimension
For billing questions, see Contacts
Outreach CPTs
CPT Modifier
(if needed)
Quantity Description Comments
84484 ​
For most current information refer to the Marshfield Laboratory online reference manual.